Aehr Test Systems, Inc.
Latest List Rankings
Current Synopsis
Aehr is the highest-beta name in this group: a small-cap semiconductor test-and-burn-in supplier trying to ride multiple AI hardware reliability waves at once. Its FOX-XP, FOX-NP, FOX-CP, WaferPak, DiePak, Sonoma, Tahoe, and Echo systems support wafer-level, die/module-level, package-level, and system-level burn-in for devices including silicon carbide power semis, processors, memory, photonics, integrated optical devices, and custom AI processors. The current financials are still messy — Q3 FY26 revenue fell to $10.3M and GAAP net loss widened to $3.2M — but bookings improved sharply. Aehr reported $37.2M in quarterly bookings, book-to-bill above 3.5x, backlog of $38.7M, and effective backlog of $50.9M including post-quarter bookings. Upside depends on AI package-level burn-in, silicon photonics, and power semiconductor demand converting into production orders.
Current Pillar Scores
Value Gap score from the May refreshed model: 27.2/100.
Earnings Momentum score from the May refreshed model: 50.0/100.
May 2x refresh: AEHR’s April 2026 release tied bookings strength to AI and data-center infrastructure demand, including wafer-level burn-in and package-level burn-in applications. Management expects a near-term follow-on production order from its lead hyperscale customer for PLBI systems for custom AI processors. It also called out a new high-power FOX-XP silicon photonics customer win for hyperscale data-center optical interconnects. The catalyst is order conversion from prototype/qualification to production burn-in capacity.
Technical Setup score from the May refreshed model: 70.0/100.
May refresh uses the real BRRR Buzz Score engine, not the fallback volume proxy. Current Buzz Score: 59.8/100, built from Google 50.0; Reddit 80.0; Wikipedia 50.0; Options 70.0; Short interest 45.0. Divergence read: Buzz falling (60) but price up (+11.3%) = EXHAUSTION.
The 2x path is order conversion. If Q3 bookings are the start of a production ramp rather than a one-off, Aehr can swing from depressed revenue/losses toward operating leverage. Management expects FY26 revenue to come in on the high side of $45M-$50M and second-half bookings at the high end of $60M-$80M. A credible FY27 acceleration from AI processors, silicon photonics, and power semis could reset expectations quickly.
Current Path to Target
The 2x path is order conversion. If Q3 bookings are the start of a production ramp rather than a one-off, Aehr can swing from depressed revenue/losses toward operating leverage. Management expects FY26 revenue to come in on the high side of $45M-$50M and second-half bookings at the high end of $60M-$80M. A credible FY27 acceleration from AI processors, silicon photonics, and power semis could reset expectations quickly.
Current Key Risk
AEHR is highly timing- and customer-concentration-sensitive. Revenue depends on large system orders that can shift between quarters, prior EV/power-semiconductor softness has already pressured results, and the company filed for up to $60M ATM share sales, creating dilution risk.
Current Key Metrics
BRRR Appearance History
Current analysis stays canonical. This is the compact scoreboard of where the name has shown up across monthly BRRR lists.
Subscribe for monthly updates on this stock and the full rankings
Keep the latest thesis current, while the appearance history shows how conviction evolved over time.
Subscribe Free →